Flibanserin Panel Review Will Pivot On Measurement Of Sexual Desire

FDA's Reproductive Health Drugs Advisory Committee will weigh the best method for assessing the efficacy of Boehringer Ingelheim's Girosa for hypoactive sexual desire disorder in premenopausal women.